Literature DB >> 9529487

Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations.

S Gansauge1, R M Schmid, J Muller, G Adler, T Mattfeldt, H G Beger.   

Abstract

BACKGROUND: In patients suffering from chronic pancreatitis the risk for the development of pancreatic cancer ranges from 4 to 6 per cent. Various mutations are associated with pancreatic cancer, especially of p53 and K-ras. The incidence of these mutations in resected chronic pancreatitic tissue was investigated.
METHODS: In the present study DNA from 80 samples of tissue from patients with chronic pancreatitis was isolated and subjected to single-strand conformation polymorphism (SSCP) analysis of p53 exons 5-9 and restriction fragment length polymorphism analysis of K-ras (codon 12).
RESULTS: No mutations in the K-ras gene were detected. On SSCP analysis, eight of 80 cases of chronic pancreatitis showed alterations (two in exon 5, four in exon 6, two in exon 7). DNA sequence analysis revealed one deletion of 21 amino acids (exon 5), four polymorphisms in exon 6 with no change in the amino acid sequence, one point mutation in exon 5, and two point mutations located in the intron between exons 6 and 7.
CONCLUSION: These data show that in some cases of chronic pancreatitis mutations in the p53 gene occur without morphological evidence of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529487     DOI: 10.1046/j.1365-2168.1998.00630.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

1.  Detection of oncogenes in chronic pancreatitis.

Authors:  D Paramythiotis; J Kleeff; J Schmidt; M W Büchler; H Friess
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

2.  K-ras and Dpc4 mutations in chronic pancreatitis: case series.

Authors:  Marijana Popović Hadzija; Marina Korolija; Jasminka Jakić Razumović; Pajica Pavković; Mirko Hadzija; Sanja Kapitanović
Journal:  Croat Med J       Date:  2007-04       Impact factor: 1.351

3.  Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma.

Authors:  E Heinmöller; W Dietmaier; H Zirngibl; P Heinmöller; W Scaringe; K W Jauch; F Hofstädter; J Rüschoff
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

Review 4.  K-Ras mutations and benign pancreatic disease.

Authors:  M Löhr; P Maisonneuve; A B Lowenfels
Journal:  Int J Pancreatol       Date:  2000-04

Review 5.  Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15-year experience.

Authors:  De-Qing Mu; You-Shu Peng; Qiao-Jian Xu
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 6.  Chronic Pancreatitis and Pancreatic Cancer.

Authors:  Xiangyu Kong; Tao Sun; Fanyang Kong; Yiqi Du; Zhaoshen Li
Journal:  Gastrointest Tumors       Date:  2014-07-18

7.  Identification of potential serum exosomal microRNAs involved in acinar-ductal metaplasia that is a precursor of pancreatic cancer associated with chronic pancreatitis.

Authors:  Li-Ping Sheng; Chao-Qun Han; Chi Nie; Tao Xu; Kun Zhang; Xuan-Ji Li; Xin-Ru Xie; Rong Lin; Zhen Ding
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

8.  Pancreatic Cancer-Related Mutational Burden Is Not Increased in a Patient Cohort With Clinically Severe Chronic Pancreatitis.

Authors:  Robert W Cowan; Erica D Pratt; Jin Muk Kang; Jun Zhao; Joshua J Wilhelm; Muhamad Abdulla; Edmund M Qiao; Luke P Brennan; Peter J Ulintz; Melena D Bellin; Andrew D Rhim
Journal:  Clin Transl Gastroenterol       Date:  2021-11-18       Impact factor: 4.488

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.